The fact that differentiation between classic and occult CNV and the recognition of the lesion components was not established until later on in the course of macular photocoagulation trials may ...

Ocugen (OCGN) announced positive preliminary efficacy and safety data from the Phase 1 dose-escalation portion of the Phase 1/2 OCU410 ArMaDa ...

A 72-year-old woman presented with a slightly erythematous macular lesion measuring 333 cm, with undefined borders, on the left temporal area of the face. The patient could not state how long ago ...

Geographic atrophy is an advanced form of dry age-related macular degeneration that causes ... can slow the progression of geographic atrophy lesions. While they can't reverse vision loss, they ...

In a clinical trial, lampalizumab treatment (right) prevented retinal lesion growth and eye deterioration for 18 months in patients with dry age-related macular degeneration. Disclaimer ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...